
Overview
Background
Prof Michael Barras is the Director of Pharmacy at the Princess Alexandra Hospital and a Research conjoint with the School of Pharmacy (Hospital 0.8 FTE / UQ 0.2 FTE). He currently supervises 8 HDR students who are conducting research related to medication safety, health informatics and advanced scope clinical pharmacy. He has a strong interest in designing, testing and monitoring individualised dosing strategies for high-risk patients in the hospital setting. Michael has many significant research relationships in hospital, university, and industry settings. He is a member of the SoP research committee.
Availability
- Professor Michael Barras is:
- Not available for supervision
Works
Search Professor Michael Barras’s works on UQ eSpace
2018
Journal Article
Endothelial function and dysfunction: impact of metformin
Nafisa, Asma, Gray, Susan G., Cao, Yingnan, Wang, Tinghuai, Xu, Suowen, Wattoo, Feroza H., Barras, Michael, Cohen, Neale, Kamato, Danielle and Little, Peter J. (2018). Endothelial function and dysfunction: impact of metformin. Pharmacology and Therapeutics, 192, 150-162. doi: 10.1016/j.pharmthera.2018.07.007
2018
Journal Article
Using Discursis to enhance the qualitative analysis of hospital pharmacist-patient interactions
Chevalier, Bernadette A. M., Watson, Bernadette M., Barras, Michael A., Cottrell, William N. and Angus, Daniel J. (2018). Using Discursis to enhance the qualitative analysis of hospital pharmacist-patient interactions. PLoS One, 13 (5) e0197288, e0197288. doi: 10.1371/journal.pone.0197288
2018
Journal Article
The SHPA Medal of Merit 2017 Oration
Barras, Michael (2018). The SHPA Medal of Merit 2017 Oration. Pharmacy Growth, Research, Innovation and Training, 2 (1). doi: 10.24080/grit.1085
2018
Journal Article
Systematic review of predictive risk models for adverse drug events in hospitalised patients
Falconer, Nazanin, Barras, Michael and Cottrell, Neil (2018). Systematic review of predictive risk models for adverse drug events in hospitalised patients. British journal of clinical pharmacology, 84 (5), 846-864. doi: 10.1111/bcp.13514
2018
Conference Publication
Dosing of Unfractionated Heparin in obese patients at the Princess Alexandra Hospital
George, C., Winckel, K., Barras, M., Coombes, J. and Cottrell, N. (2018). Dosing of Unfractionated Heparin in obese patients at the Princess Alexandra Hospital. Translational Research Institute Symposium, Brisbane, QLD, Australia, August 2018.
2018
Journal Article
Monitoring of tobramycin exposure: what is the best estimation method and sampling time for clinical practice?
Gao, Yanhua, Hennig, Stefanie and Barras, Michael (2018). Monitoring of tobramycin exposure: what is the best estimation method and sampling time for clinical practice?. Clinical Pharmacokinetics, 58 (3), 389-399. doi: 10.1007/s40262-018-0707-9
2017
Journal Article
Bayesian estimation of tobramycin exposure in patients with cystic fibrosis — an update
Gao, Yanhua, Barras, Michael and Hennig, Stefanie (2017). Bayesian estimation of tobramycin exposure in patients with cystic fibrosis — an update. Antimicrobial Agents and Chemotherapy, 62 (3) e01972, e01972-17. doi: 10.1128/AAC.01972-17
2017
Journal Article
Hospital pharmacists’ and patients’ views about what constitutes effective communication between pharmacists and patients
Chevalier, Bernadette A. M., Watson, Bernadette M., Barras, Michael A. and Cottrell, William N. (2017). Hospital pharmacists’ and patients’ views about what constitutes effective communication between pharmacists and patients. International Journal of Pharmacy Practice, 26 (5), 450-457. doi: 10.1111/ijpp.12423
2017
Journal Article
A word to the wise
Barras, M.A. (2017). A word to the wise. Pharmacy GRIT, Autumn, 16-18.
2017
Journal Article
Individualised medicine: why we need Bayesian dosing
Donagher, Joni, Martin, Jennifer H. and Barras, Michael A. (2017). Individualised medicine: why we need Bayesian dosing. Internal Medicine Journal, 47 (5), 593-600. doi: 10.1111/imj.13412
2017
Journal Article
Investigating strategies used by hospital pharmacists to effectively communicate with patients during medication counselling
Chevalier, Bernadette A. M., Watson, Bernadette M., Barras, Michael A. and Cottrell, William Neil (2017). Investigating strategies used by hospital pharmacists to effectively communicate with patients during medication counselling. Health Expectations, 20 (5), 1121-1132. doi: 10.1111/hex.12558
2017
Journal Article
The type and incidence of adverse drug events in ageing medical inpatients and their effect on length of hospital stay
Paradissis, Chariclia, Coombes, Ian D., Donovan, Peter, Doran, Elizabeth, Mckean, Mitchell and Barras, Michael A. (2017). The type and incidence of adverse drug events in ageing medical inpatients and their effect on length of hospital stay. Journal of Pharmacy Practice and Research, 47 (5), 347-354. doi: 10.1002/jppr.1255
2017
Journal Article
A randomized trial of olanzapine versus palonosetron versus infused ondansetron for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients undergoing hematopoietic stem cell transplantation
Nakagaki, Midori, Barras, Michael, Curley, Cameron, Butler, Jason P. and Kennedy, Glen A. (2017). A randomized trial of olanzapine versus palonosetron versus infused ondansetron for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients undergoing hematopoietic stem cell transplantation. Supportive Care in Cancer, 25 (2), 1-7. doi: 10.1007/s00520-016-3445-2
2017
Conference Publication
Identifying inpatients at high risk of adverse drug events: Systematic review of predictive risk scores
Falconer, Nazanin, Barras, Michael and Cottrell, Neil (2017). Identifying inpatients at high risk of adverse drug events: Systematic review of predictive risk scores. Society of Hospital Pharmacists of Australia conference, Sydney, Australia, November 2017.
2017
Journal Article
Drug dosing in obese adults
Barras, Michael and Legg, Amy (2017). Drug dosing in obese adults. Australian Prescriber, 40 (5), 189-193. doi: 10.18773/austprescr.2017.053
2017
Conference Publication
Identifying Clinical Pharmacist Patient Prioritisation Criteria
Falconer, Nazanin, Barras, Michael and Cottrell, Neil (2017). Identifying Clinical Pharmacist Patient Prioritisation Criteria. Australasian Pharmaceutical Science Association (APSA) and the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Joint Scientific Meeting, Brisbane QLD Australia, December 2017.
2017
Conference Publication
The influence of sampling time on estimated tobramycin exposure in patient with cystic fibrosis
Gao, Yanhua, Hennig, Stefanie and Barras, Michael (2017). The influence of sampling time on estimated tobramycin exposure in patient with cystic fibrosis. Australian Society of Clinical Pharmacology and Toxicology National Conference, Brisbane, QLD, Australia, 5 – 8 December 2017.
2016
Journal Article
Bayesian estimation of tobramycin exposure in cystic fibrosis
Barras, Michael A., Serisier, David, Hennig, Stefanie, Jess, Katrina and Norris, Ross L. G. (2016). Bayesian estimation of tobramycin exposure in cystic fibrosis. Antimicrobial Agents and Chemotherapy, 60 (11), 6698-6702. doi: 10.1128/AAC.01131-16
2016
Journal Article
Inpatient smoking cessation – turn to your clinical pharmacist
Snoswell, Centaine and Barras, Michael (2016). Inpatient smoking cessation – turn to your clinical pharmacist. Australian and New Zealand Journal of Public Health, 40 (5), 498-498. doi: 10.1111/1753-6405.12567
2016
Journal Article
Examining hospital pharmacists' goals for medication counselling within the communication accommodation theoretical framework
Chevalier, Bernadette A. M., Watson, Bernadette M., Barras, Michael A. and Cottrell, William Neil (2016). Examining hospital pharmacists' goals for medication counselling within the communication accommodation theoretical framework. Research in Social and Administrative Pharmacy, 12 (5), 747-755. doi: 10.1016/j.sapharm.2015.10.008
Supervision
Availability
- Professor Michael Barras is:
- Not available for supervision
Supervision history
Current supervision
-
Doctor Philosophy
A pharmacist to improve medication management and patient outcomes for critically ill patients in the emergency department.
Principal Advisor
-
Doctor Philosophy
Patient-Centred Pharmacy Care in the hospital setting
Principal Advisor
Other advisors: Professor Ian Coombes
-
Master Philosophy
Pharmacist led post discharge medication review in patients at high-risk of medication related harm
Associate Advisor
Other advisors: Dr Carla Scuderi, Professor Ian Coombes
-
Doctor Philosophy
Implementing a Medication review pharmacy clinic and the potential impact on patient care.
Associate Advisor
Other advisors: Dr Centaine Snoswell, Dr Holly Foot
-
Doctor Philosophy
A predictive model for 30-day hospital readmission in Cardiology patients
Associate Advisor
Other advisors: Professor Ian Coombes
-
Doctor Philosophy
Quality and Safe Use of Clozapine
Associate Advisor
Other advisors: Associate Professor Nicola Warren, Professor Steve Kisely, Professor Dan Siskind
-
Doctor Philosophy
Quality and Safe Use of Clozapine
Associate Advisor
Other advisors: Associate Professor Nicola Warren, Professor Steve Kisely, Professor Dan Siskind
-
Master Philosophy
Pharmacist led post discharge medication review in patients at high-risk of medication related harm
Associate Advisor
Other advisors: Professor Ian Coombes
-
Doctor Philosophy
A predictive model for 30-day hospital readmission in Cardiology patients
Associate Advisor
Other advisors: Professor Ian Coombes
-
Doctor Philosophy
Voluntary assisted dying services in Queensland
Associate Advisor
Other advisors: Associate Professor Adam La Caze
-
Doctor Philosophy
Development and Integration of a Medication Harm Prediction Tool within an Australian Digital Hospital
Associate Advisor
Other advisors: Professor Ian Scott
Completed supervision
-
2024
Doctor Philosophy
Exploring the impact of electronic medication management on the safety and quality of therapeutic anticoagulation
Principal Advisor
Other advisors: Professor Clair Sullivan, Dr Lee Woods
-
2024
Doctor Philosophy
Medication harm in patients after acute myocardial infarction
Principal Advisor
Other advisors: Professor Ian Coombes
-
2022
Doctor Philosophy
Cellular studies on the role of matrix dependent mechanism of atherosclerosis: role of transcription factor Smad and its phosphorylation
Associate Advisor
-
2022
Doctor Philosophy
Aspirin for the Prophylaxis of Venous Thromboembolic Events
Associate Advisor
-
2020
Doctor Philosophy
Prioritising patients at high-risk of medication harm: Development and validation of risk prediction models
Associate Advisor
-
2017
Doctor Philosophy
Investigating the effectiveness of communication taking place between hospital pharmacists and patients during medication counselling
Associate Advisor
Other advisors: Honorary Professor Bernadette Watson
Media
Enquiries
For media enquiries about Professor Michael Barras's areas of expertise, story ideas and help finding experts, contact our Media team: